NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Measurement of serum and plasma osmolality in healthy young humans--influence of time and storage conditions.

Author(s): Seifarth CC, Miertschischk J, Hahn EG, Hensen J

Publication: Clin Chem Lab Med, 2004, Vol. 42, Page 927-32

PubMed ID: 15387444 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of storage, anticoagulant, thawing method and preservation with bacitracin and neomycin on the osmolality of serum and plasma.

Conclusion of Paper

Serum osmolality was stable in specimens stored at -78 degrees C and thawed at 37 degrees C for 5 min, but it was affected by storage at room temperature, 7 degrees C, or -21 degrees C, or thawing for 12 h at 7 degrees C. The osmolality of lithium heparin-plasma and potassium EDTA (K3EDTA)-plasma showed changes during storage similar to serum, but plasma had higher initial osmolality. Adding bacitracin and neomycin to the specimens slightly attenuated the effects of storing lithium heparin-plasma at -21 degrees C, but significant storage effects were still noted by day 14.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of storage, anticoagulant, thawing method and preservation with bacitracin and neomycin on the osmolality of serum and plasma.

    Summary of Findings:

    A significant increase in serum osmolality was observed in specimens stored at room temperature for 3 days or more or at 7 degrees C for 28 days or more. In contrast, storage at 7 degrees C for 1 day or -21 degrees C for 14 days or more resulted in decreased serum osmolality, and storage at -78 degrees C for up to 56 days did not affect serum osmolality. The osmolality of serum frozen at -78 degrees C was elevated when specimens were thawed for 12 h at 7 degrees C instead of for 5 min at 37 degrees C. The osmolality of lithium heparin-plasma decreased during storage at -21 degrees C and was not significantly different from that of serum. The authors report that K3EDTA-plasma showed changes similar to serum during storage but had higher initial osmolality. Adding bacitracin and neomycin slightly attenuated the effects of storing lithium heparin-plasma at -21 degrees C, but significant storage effects were still noted by day 14 (0=0.004).

    Biospecimens
    Preservative Types
    • None (Fresh)
    • Other Preservative
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Small molecule Clinical chemistry/auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Storage duration <60 min
    1 days
    3 days
    14 days
    28 days
    56 days
    Storage Storage temperature -78 degrees C
    -21 degrees C
    7 degrees C
    22 degrees C
    Biospecimen Aliquots and Components Blood and blood products Plasma
    Serum
    Storage Thaw temperature/condition 37 degrees C
    7 degrees C
    Storage Thaw duration 5 min
    12 h
    Biospecimen Preservation Type of fixation/preservation Frozen
    None (fresh)
    Refrigeration
    Biospecimen Preservation Fixative additive/buffer Bacitracin
    Neomycin
    None
    Biospecimen Acquisition Anticoagulant Potassium EDTA
    Lithium heparin

You Recently Viewed  

News and Announcements

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • Most Downloaded SOPs in January and February of 2024

  • More...